相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adoptive Immunotherapy for Cancer or Viruses
Marcela V. Maus et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Antibody-modified T cells: CARs take the front seat for hematologic malignancies
Marcela V. Maus et al.
BLOOD (2014)
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Yang Xu et al.
BLOOD (2014)
Engineered T cells for cancer treatment
Usanarat Anurathapan et al.
CYTOTHERAPY (2014)
A Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells
Marleen M. van Loenen et al.
HAEMATOLOGICA (2014)
Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
Raquel Gomez-Eerland et al.
HUMAN GENE THERAPY METHODS (2014)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Hiroki Torikai et al.
BLOOD (2013)
Clinical-scale selection and viral transduction of human na⟨ve and central memory CD8+ T cells for adoptive cell therapy of cancer patients
Anna Casati et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Integrated Clinical Scale Manufacturing System for Cellular Products Derived by Magnetic Cell Separation, Centrifugation and Cell Culture
Michael Apel et al.
CHEMIE INGENIEUR TECHNIK (2013)
A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI)
Lisa K. McNeil et al.
CYTOMETRY PART A (2013)
Simplified process for the production of anti-CD19-CAR-engineered T cells
Barbara Tumaini et al.
CYTOTHERAPY (2013)
Critical assessment of automated flow cytometry data analysis techniques
Nima Aghaeepour et al.
NATURE METHODS (2013)
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
Seitaro Terakura et al.
BLOOD (2012)
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Hiroki Torikai et al.
BLOOD (2012)
Will T-cell therapy for cancer ever be a standard of care?
M. K. Brenner
CANCER GENE THERAPY (2012)
Adoptive Cell Therapy for Lymphoma with CD4 T Cells Depleted of CD137-Expressing Regulatory T Cells
Matthew J. Goldstein et al.
CANCER RESEARCH (2012)
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
Daniel W. Lee et al.
CLINICAL CANCER RESEARCH (2012)
Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer
Thomas Decker et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Sorting Through Subsets: Which T-Cell Populations Mediate Highly Effective Adoptive Immunotherapy?
Christopher A. Klebanoff et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Simplified Method of the Growth of Human Tumor Infiltrating Lymphocytes in Gas-permeable Flasks to Numbers Needed for Patient Treatment
Jianjian Jin et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor
Robert P. T. Somerville et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Peak serum: implications of serum supply for cell therapy manufacturing
David A. Brindley et al.
REGENERATIVE MEDICINE (2012)
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
Christian S. Hinrichs et al.
BLOOD (2011)
Lentiviral vector common integration sites in preclinical models and a clinical trial reflect a benign integration bias and not oncogenic selection
Alessandra Biffi et al.
BLOOD (2011)
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma
Chrystal U. Louis et al.
BLOOD (2011)
Lentiviral Vectors: Their Molecular Design, Safety, and Use in Laboratory and Preclinical Research
Boro Dropulic
HUMAN GENE THERAPY (2011)
Biomarkers in T cell therapy clinical trials
Michael Kalos
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Harmonization of Immune Biomarker Assays for Clinical Studies
Sjoerd H. van der Burg et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Treating cancer with genetically engineered T cells
Tristen S. Park et al.
TRENDS IN BIOTECHNOLOGY (2011)
Analysis of Lentiviral Vector Integration in HIV plus Study Subjects Receiving Autologous Infusions of Gene Modified CD4+T Cells
Gary P. Wang et al.
MOLECULAR THERAPY (2009)
Adoptive transfer of effector CD8(+) T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
Martin A. Pule et al.
NATURE MEDICINE (2008)
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias
Judith E. Karp et al.
BLOOD (2007)
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
DL Porter et al.
BLOOD (2006)
Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells
L Gattinoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
分享论文
